Introduction
Owing to poor treatment outcomes from orthodox medical therapies, patients are increasingly turning to complementary and alternative medicine (CAM) for the relief of pain-related conditions. 1 CAM has been used to bring relief in lieu of or as an adjunct to conventional medical therapies. Clinical observations have shown that herbal remedies relieve cancer pain and other forms of pain in more than half of their users. [2] [3] [4] The use of herbal medicine, an ancient form of treatment known to man, is common to all peoples and cultures. 5 For instance, there is a history of lifetime use of CAM by 30%-60% and 47% of the population of USA 6, 7 and UK, 8 respectively, while 10% of hospital physicians in the UK use it as part of their clinical practice. 9 High-quality researches into the efficacy of herbal medicine are relatively few compared to the growing worldwide interest in it. Moreover, the efficacy, safety, and toxicity of some herbs being used in the relief of chronic pain and the analgesic mechanisms involved remain unclear.
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Many herbs and vegetables derive their local names from their speculated actions on the human body. For instance, Hybanthus enneaspermus leaves are known as "ēwé ābíwéré" in Yoruba language (meaning a leaf that induces painless or fast delivery or both during labor) because of their widespread ethnopharmacological use as a traditional analgesic herb, especially to reduce labor pain in pregnant women.
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While Awobajo et al 12 demonstrated the uterotonic effect of their aqueous extract in isolated uterine muscles of pregnant rats, Afolabi et al 11 demonstrated the dose-dependent antinociceptive effect of their ethanol extract in male Wistar rats. Phytochemical screening of H. enneaspermus leaves extract 13 has shown that the leaves contain saponins, tannins, and flavonoids, which are known to have analgesic effect in animals.
14, 15 Afolabi et al 11 speculated that the anti-nociceptive effect exhibited by the ethanol extract of H. enneaspermus leaves (EEHE) might be due to the synergistic action of its phytochemical components. However, the pharmacological mechanisms involved in the analgesic action of the leaves have not been determined. We investigated the involvement of histamine, opioid, and adrenergic receptors in the EEHEinduced analgesia using the tail immersion and formalin tests.
Materials and methods animals
Numerous studies have reported sex differences in pain perception, with lower pain thresholds and tolerance in females than in males. However, there have been conflicting reports on the modulation of nociception by estradiol, as both hypoalgesia 16, 17 and hyperalgesia 18 have been associated with it, in addition to the reported effect of estrous cycle on nociception in female rats. 19, 20 Therefore, we opted to use male rats for the investigation of the mechanisms involved in the antinociceptive effect of H. enneaspermus leaves in this study.
Male Wistar rats (140±20 g) used for this study were obtained from the Institute of Medical Research and Training, University of Ibadan College Hospital, Nigeria; they were housed at room temperature with unrestricted access to food and tap water and maintained on a daily light/dark cycle. In addition to experimental protocol approval by the research ethics committee of the College of Health Sciences, Ladoke Akintola University of Technology, Ogbomoso, Nigeria, "principles of laboratory animal care (NIH publication No. 85-23, revised 1985)" were followed.
Preparation of eehe
Hybanthus enneaspermus leaves were bought from a farmer at Owode market in Ogbomoso, Oyo, Nigeria, and authenticated by Mr KA Adeniji of the Forestry Research Institute of Nigeria, Ibadan, where a specimen voucher number FHI 1008871 was deposited. They were ground into a moderately coarse powder (using pestle and mortar) after air-drying them in a well-ventilated and shaded room. About 170 g of the dried powder was then extracted with 95% ethanol for 72 hours using the Soxhlet apparatus as previously described. 21 A semisolid extract (10.2 g, 6%) was obtained by evaporating ethanol with a rotary evaporator and then refrigerated until further use.
experimental protocol Tail immersion test
Forty-two male rats were randomized into seven treatment groups (n=6 rats in each group). Group I (control) received distilled water (10 mL/kg) while groups II and III received acetaminophen (the reference drug, 100 mg/kg ip) and EEHE (1000 mg/kg po), 11 respectively. Groups IV-VII were pretreated with cimetidine (50 mg/kg ip), 22 naloxone (5 mg/kg ip), 23 propranolol (0.15 mg/kg ip), 24 and prazosin (0.15 mg/kg ip), 25 respectively, 20 minutes before EEHE (1000 mg/kg po) treatment. The tail immersion test was performed 1 hour after the final treatment.
Animals were handled for 3 minutes and habituated to the testing room for 1 hour on two occasions before the day of testing and again on the day of testing. Each rat was removed from its home cage and gently restrained in a towel, and ~5 cm of its tail from the tip was immersed in a water bath (52±0.5°C) in order to determine the tail-flick latency (TFL) period. The TFL period, recorded by stopwatch, 26 is the time (in seconds) taken for the animal to clearly withdraw or flick its tail out of the water.
Formalin test
Another 42 male rats were randomly divided into seven groups (n=6 rats in each group) as stated earlier for the tail immersion test. Animals were habituated to the 30 cm 3 transparent Plexiglas observation box for 30 minutes on two occasions before the day of testing and immediately before testing. Each rat was removed from the observation box and restrained in a towel, followed by drug(s) treatment according to the treatment group. Then 1 hour after the final treatment, 0.05 mL of 2.5% formalin was injected into the plantar surface of the left hind paw of the animal. The animal was then returned into the glass chamber for observation. The time spent licking or biting the paw during the first 5 minutes and 15-30 minutes of formalin injection represents the early and late phases of the nociceptive response, respectively. 27 The Figure 1 ).
Opioidergic pathway is involved in eeheinduced anti-inflammatory activity Figure 2B ).
Discussion
Large numbers of receptor systems, including opioid, histaminergic, cholinergic, adrenergic, and glutaminergic systems, have been reported to be involved in nociception of many herbs. 29 While some of these receptor systems mediate nociception centrally, others mediate it peripherally. 30 We have suggested that the anti-nociceptive action of EEHE is both centrally-and peripherally-mediated. 11 The present study validates our previously reported anti-nociceptive effect of EEHE and provides additional information that opioidergic pathway greatly contributes to EEHE-induced analgesia during both TFL and formalin tests, while histaminergic and adrenergic pathways also partly contribute to it during the tail-flick test only but not during the formalin test.
The models of nociception selected for this study are such that both centrally-and peripherally-mediated effects were assessed. While the TFL test assessed centrally-mediated thermal nociception, 31 the formalin-induced paw licking test assessed the centrally-mediated but chemically-induced nociception and the peripherally-mediated inflammatory nociception. 32 The tail-flick test, which is a brief, rapid pain, is a reflex to noxious stimulation that is mediated by spinal cord and results in tail withdrawal at the lowest possible threshold for pain. The formalin test, by contrast, is a prolonged, steady pain which measures the response to a long-lasting nociceptive stimulus and, therefore, resembles clinical pain. 32 The early phase is thought to act by direct chemical stimulation of nociceptors, 33 while the late phase response acts through inflammation 34 mediated by histamine, serotonin, and prostaglandins. 30 Centrally acting drugs like narcotics inhibit both phases of formalin-induced pain, while peripherally acting drugs such as aspirin only inhibit the late phase. 29 Some differences in the pattern of results obtained from brief or phasic pain test (e.g., tail-flick and hot plate tests) and the prolonged or steady pain (e.g., formalin test) have been documented. For instance, morphine analgesia was unaffected by adrenergic blockers in the tail-flick and hot plate tests but was strikingly antagonized by them in the formalin test. 35 Also, morphine analgesia that was decreased by anti-serotonergic drugs in the tail-flick test was otherwise increased in the formalin test. 36 In this study, histamine and adrenergic receptors (alpha and beta) were involved in the EEHE-induced analgesia in the brief pain (TFL test) but were not involved in the prolonged or steady pain (formalin test). This observation is similar to the previously reported differences in the neuronal pathways involved in the morphine-induced analgesia following thermal and chemical pain assessed by tail-flick and formalin tests, respectively. 37 Our data thus support the contention that different analgesiaproducing systems are involved in different pain tests.
Narcotic analgesics act by binding to opiate receptors in the midbrain periaqueductal gray matter. The binding leads to the suppression of responses of the spinal neurons to noxious stimuli by the activated descending brain stem inhibitory systems. 37 The present study suggests that administration of EEHE caused partial inhibition of nociception via the histaminergic and noradrenergic mechanisms but almost complete inhibition of nociception via the opioidergic pathway.
Previous studies have shown the presence of opiate receptors in the endothelium, 38 sympathetic fibers, 39, 40 leukocytes, 40, 41 and peripheral afferent fibers, 42, 43 all of which are involved in inflammation. The stimuli for the early and late phases of the formalin test have been shown to be different, as that of the former is a direct chemical stimulation of the nociceptors 
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Hybanthus enneaspermus and nociception while the latter involves inflammation. 30, 44 An observation of abolishment of the centrally mediated and peripherally mediated anti-nociceptive effect of EEHE by opiate receptor blocker (naloxone) not only suggests the involvement of opioidergic pathway in its analgesic action but also shows a possibility of the presence of opiate-like substances in EEHE.
Conclusion
This study provides information on the pharmacological mechanisms involved in EEHE-induced analgesia. It suggests that the analgesic effect of EEHE in different pain types may involve different neural mechanisms. It further shows that the histamine and adrenergic pathways partly contribute to the EEHE-induced analgesia during the centrally-mediated thermal but not chemical pain and peripherally-mediated inflammatory pain, while the opioidergic pathway plays a predominant role during both centrally-and peripherallymediated pain types.
